Brought to you by
SERAM 2014 / S-0421
Lesiones suprarrenales: caracterización por imagen con correlación patológica y algoritmo diagnóstico.
Congress: SERAM 2014
Poster No.: S-0421
Type: Presentación Electrónica Educativa
Keywords: Neoplasia, Evaluación tecnológica, Ultrasonidos, TC, RM, , Abdomen
Authors: R. Mut Pons1, E. Miralles Aznar1, N. Bernal Garnés1, C. F. MUÑOZ NÚÑEZ2; 1Torrevieja/ES, 2ES


1. Giles WL. Boland, et al. Incidental adrenal lesions: principles, techniques and algorithms for imaging characterization. Radiology 2008; 249: 756-775.


2. Khaled M. Elsayes, et al. Adrenal masses: MR imaging features with pathologic correlation. Radiographics 2004; 24: 73-86.


3. William W. Mayo-Smith, et al. From the RSNA refresher courses: state-of-the-art adrenal imaging. Radiographics 2001; 21: 995-1012.


4. Minal J. Sangwaiya, et al. Incidental adrenal lesions: accuracy of characterization with contrast-enhanced wash out multidetector CT-10 minute delayed imaging protocol revisited in a large patient cohort. Radiology 2010; 256: 504-510.


5. Peter F. Hahn, et al. Adrenal lesions: attenuation measurement differences between CT scanners. Radiology 2006; 240: 458-463.


6. Daniele Marin, et al. Characterization of adrenal lesions: comparison of 2D and 3D dual gradient-echo MR imaging at 3T-preliminary results. Radiology 2010; 254: 179-187.


7. Young WF Jr. The incidentally discovered adrenal mass. N Engl J Med 2007; 356: 601-610.


8. Dunnick NR, Korobkin M. Imaging of adrenal incidentalmomas. AJR Am J Roentgenol 2002; 179: 559–568.


9. Song JH, Chaudhry FS, Mayo-Smith WW. The incidental indeterminate adrenal mass on CT: prevalence of adrenal disease in 1.049 consecutive adrenal masses in patients with no known malignancy. AJR Am J Roentgenol 2008; 190: 1163-1168.


10. Slattery JM, Blake MA, Kalra MK, et al. Adrenocortical carcinoma: contrast washout characteristics on CT. AJR Am J Roentgenol 2006; 187: 21-24.


11. Szolar DH, Melvyn Korobkin M, Reittner P, et al. Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT. Radiology 2005; 234: 479–485.


12. Benitah N, Yeh BM, Qayyum A. Minor morphologic abnormalities of adrenal glands at CT: prognostic importance in patients with lung cancer. Radiology 2005; 235: 517–522.


13. Jhaveri KS, Wong F, Ghai S, Haider MA. Comparison of CT histogram analysis and chemical shift MRI in the characterization of indeterminate adrenal nodules. AJR Am J Roentgenol 2006; 187: 1303-1308.


14. Haider MA, Ghai S, Jhaveri K, Lockwood G. Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role?. Radiology 2004; 231: 711-716.


15. Park BK, Kim CK, Kim B, Lee JH. Comparison of delayed enhanced CT and chemical shift MR for evaluating hyperattenuating incidental adrenal masses. Radiology 2007; 243: 760–765.


16. Blake MA, Kalra MK, Maher MM, et al. Pheochromocytoma: an imaging chameleon. Radiographics 2004; 24: 87-89.


17. Bessell-Browne R, O’Malley ME. CT of pheochromocytoma and paraganglioma: risk of adverse events with IV administration of nonionic contrast material. AJR Am J Roentgenol 2007; 188: 970–997.


18. Siegel MJ, Ishwaran H, Fletcher BD, et al. Staging of neuroblastoma at imaging: report of the Radiology Diagnostic Oncology Group. Radiology 2002; 223: 168-175.


19. Kamiyama T, et al . Distinguishing adrenal adenomas from nonadenomas: combined use of diagnostic parameters of unenhanced and short 5-minute dynamic enhanced CT protocol. Radiology 2009; 250: 474-481.


20. Frilling A , Tecklenborg K , Weber F , et al. Importance of adrenal incidentaloma in patients with a history of malignancy. Surgery 2004; 136: 1289-1296.


21. Schindera ST, et al. Effect of echo time pair selection on quantitative analysis for adrenal tumor characterization with in-phase and opposed-phase MR imaging: initial experience. Radiology 2008; 248: 140-147.

POSTER ACTIONS Add bookmark Contact presenter Send to a friend Download pdf
2 clicks for more privacy: On the first click the button will be activated and you can then share the poster with a second click.

This website uses cookies. Learn more